{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:50:53Z","timestamp":1792511453778,"version":"4.5.0"},"reference-count":97,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["3R37AI080289-11S1"],"award-info":[{"award-number":["3R37AI080289-11S1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CIVIC75N93019C00052"],"award-info":[{"award-number":["CIVIC75N93019C00052"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AI1650721"],"award-info":[{"award-number":["P01AI1650721"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AI146785"],"award-info":[{"award-number":["R01AI146785"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01CA260476 \u2013 01"],"award-info":[{"award-number":["U01CA260476 \u2013 01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI135995-02"],"award-info":[{"award-number":["U19AI135995-02"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U19AI42790-01"],"award-info":[{"award-number":["U19AI42790-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012802","name":"Ragon Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012802","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Immunology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.coi.2022.102234","type":"journal-article","created":{"date-parts":[[2022,8,13]],"date-time":"2022-08-13T17:45:12Z","timestamp":1660412712000},"page":"102234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design"],"prefix":"10.1016","volume":"78","author":[{"given":"Carl","family":"Britto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galit","family":"Alter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coi.2022.102234_bib1","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1093\/cid\/cit048","article-title":"Complex correlates of protection after vaccination","volume":"56","author":"Plotkin","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coi.2022.102234_bib2","first-page":"21","article-title":"Edward Jenner and the history of smallpox and vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"Proc (Bayl Univ Med Cent)"},{"key":"10.1016\/j.coi.2022.102234_bib3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jnnp.73.1.82","article-title":"Louis Pasteur and Rabies: a brief note","volume":"73","author":"Pearce","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.coi.2022.102234_bib4","first-page":"1384","article-title":"Dr. Koch\u2019s Postulates on JSTOR","volume":"1","year":"1910","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2022.102234_bib5","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.coi.2022.102234_bib6","article-title":"Vaccine development throughout history","volume":"13","author":"Saleh","year":"2021","journal-title":"Crit Care"},{"key":"10.1016\/j.coi.2022.102234_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1073\/pnas.1819612116","article-title":"On the mechanisms of conjugate vaccines","volume":"116","author":"Rappuoli","year":"2019","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2022.102234_bib8","unstructured":"Influenza HistoricTimeline | Pandemic Influenza (Flu) |CDChttps:\/\/www.cdc.gov\/flu\/pandemic-resources\/pandemic-timeline-1930-and-beyond.htmAccessed:2022-08-10."},{"key":"10.1016\/j.coi.2022.102234_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41573-019-0056-x","article-title":"Next-generation influenza vaccines: opportunities and challenges","volume":"19","author":"Wei","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coi.2022.102234_bib10","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fimmu.2020.590780","article-title":"Major scientific hurdles in HIV vaccine development: historical perspective and future directions","volume":"11","author":"Ng\u2019uni","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-020-0196-3","article-title":"Malaria vaccines since 2000: progress, priorities, products","volume":"5","author":"Duffy","year":"2020","journal-title":"npj Vaccin"},{"key":"10.1016\/j.coi.2022.102234_bib12","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41579-021-00573-0","article-title":"SARS-CoV-2 variants, spike mutations and immune escape","volume":"19","author":"Harvey","year":"2021","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.coi.2022.102234_sbref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41467-020-20321-x","article-title":"Stabilizing the closed SARS-CoV-2 spike trimer","volume":"12","author":"Juraszek","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.coi.2022.102234_bib15","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/s41563-020-0746-0","article-title":"Next-generation vaccine platforms for COVID-19","volume":"19","author":"van Riel","year":"2020","journal-title":"Nat Mater"},{"key":"10.1016\/j.coi.2022.102234_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-021-00292-w","article-title":"SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates","volume":"6","author":"Kyriakidis","year":"2021","journal-title":"npj Vaccin"},{"key":"10.1016\/j.coi.2022.102234_bib17","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/cis238","article-title":"Nomenclature for immune correlates of protection after vaccination","volume":"54","author":"Plotkin","year":"2012","journal-title":"Clin Infect Dis Publ Infect Dis Soc Am"},{"key":"10.1016\/j.coi.2022.102234_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s10156-013-0601-1","article-title":"Pneumococcal vaccine and opsonic pneumococcal antibody","volume":"19","author":"Song","year":"2013","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.coi.2022.102234_bib19","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccin Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110276","article-title":"Concise review on optimized methods in production and transduction of lentiviral vectors in order to facilitate immunotherapy and gene therapy","volume":"128","author":"Gouvarchin Ghaleh","year":"2020","journal-title":"Biomed Pharm"},{"key":"10.1016\/j.coi.2022.102234_sbref20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fimmu.2021.798207","article-title":"Induction of functional specific antibodies, IgG-secreting plasmablasts and memory B cells following BCG vaccination","volume":"12","author":"Bitencourt","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007643","article-title":"A comparison of antigen-specific T cell responses induced by six novel tuberculosis vaccine candidates","volume":"15","author":"Rodo","year":"2019","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.coi.2022.102234_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/14760584.6.3.441","article-title":"The next generation: tuberculosis vaccines that elicit protective CD8+ T cells","volume":"6","author":"Behar","year":"2007","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.coi.2022.102234_bib24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1128\/CVI.00131-10","article-title":"Correlates of protection induced by vaccination","volume":"17","author":"Plotkin","year":"2010","journal-title":"Clin Vaccin Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib25","first-page":"780","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/INF.0b013e3181c67f04","article-title":"Immunogenicity of a reduced schedule of pneumococcal conjugate vaccine in healthy infants and correlates of protection for serotype 6B in the united kingdom","volume":"29","author":"Goldblatt","year":"2010","journal-title":"Pedia Infect Dis J"},{"key":"10.1016\/j.coi.2022.102234_bib27","doi-asserted-by":"crossref","first-page":"5650","DOI":"10.1016\/j.vaccine.2014.08.010","article-title":"Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection","volume":"32","author":"Townsend","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2022.102234_bib28","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1172\/JCI65708","article-title":"Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity","volume":"123","author":"Ackerman","year":"2013","journal-title":"J Clin Investig"},{"key":"10.1016\/j.coi.2022.102234_bib29","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.chom.2013.02.009","article-title":"Antibody-mediated immunity against tuberculosis: Implications for vaccine development","volume":"13","author":"Achkar","year":"2013","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2022.102234_bib30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/glycob\/cwaa018","article-title":"Understanding the role of antibody glycosylation through the lens of severe viral and bacterial diseases","volume":"30","author":"Irvine","year":"2020","journal-title":"Glycobiology"},{"key":"10.1016\/j.coi.2022.102234_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009708","article-title":"Antibody-independent functions of B cells during viral infections","volume":"17","author":"Upasani","year":"2021","journal-title":"PLOS Pathog"},{"key":"10.1016\/j.coi.2022.102234_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3389\/fimmu.2019.00548","article-title":"Fc-mediated antibody effector functions during respiratory syncytial virus infection and disease","volume":"10","author":"Van Erp","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib33","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1016\/j.vaccine.2019.10.046","article-title":"Updates on immunologic correlates of vaccine-induced protection","volume":"38","author":"Plotkin","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2022.102234_bib34","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1128\/CVI.00268-16","article-title":"High concentrations of measles neutralizing antibodies and high-avidity measles IgG accurately identify measles reinfection cases","volume":"23","author":"Sowers","year":"2016","journal-title":"Clin Vaccin Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib35","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/infdis\/119.6.654","article-title":"Immunity to mumps in an institutional epidemic. Correlation of insusceptibility to mumps with serum plaque neutralizing and hemagglutination-inhibiting antibodies","volume":"119","author":"Ennis","year":"1969","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2022.102234_bib36","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.0504592102","article-title":"Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles","volume":"102","author":"Pan","year":"2005","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.coi.2022.102234_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0166-0934(81)90062-8","article-title":"Role of virus strain in conventional and enhanced measles plaque neutralization test","volume":"3","author":"Albrecht","year":"1981","journal-title":"J Virol Methods"},{"key":"10.1016\/j.coi.2022.102234_bib38","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1080\/21645515.2017.1330733","article-title":"The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: a retrospective cohort study","volume":"13","author":"La Torre","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coi.2022.102234_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fimmu.2020.02089","article-title":"Mumps outbreaks in vaccinated populations\u2014is it time to re-assess the clinical efficacy of vaccines?","volume":"11","author":"Connell","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib40","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1056\/NEJMoa1703309","article-title":"Effectiveness of a third dose of MMR vaccine for mumps outbreak control","volume":"377","author":"Cardemil","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2022.102234_bib41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/v9040077","article-title":"T. cell-mediated immunity towards Yellow Fever Virus and useful animal models","volume":"9","author":"Watson","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.coi.2022.102234_bib42","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.4049\/jimmunol.1402605","article-title":"CD8+ T cells complement antibodies in protecting against YF virus","volume":"194","author":"Bassi","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib43","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00269-18","article-title":"Breadth and functionality of Varicella-Zoster virus glycoprotein-specific antibodies identified after Zostavax vaccination in humans","volume":"92","author":"Sullivan","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coi.2022.102234_bib44","doi-asserted-by":"crossref","unstructured":"Doll KL, Harty JT. Correlates of protective immunity following whole sporozoite vaccination against malaria.\u00a0Immunol Res. 2014, doi:10.1007\/s12026-014-8525-0.","DOI":"10.1007\/s12026-014-8525-0"},{"key":"10.1016\/j.coi.2022.102234_bib45","first-page":"75","article-title":"Efficacy of RTS,S\/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5\u201317 months in Kenya and Tanzania: a randomised controlled trial","volume":"11","author":"Olutu","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.coi.2022.102234_bib46","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1073\/pnas.1621489114","article-title":"Systems analysis of protective immune responses to RTS,S malaria vaccination in humans","volume":"114","author":"Kazmin","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2022.102234_bib47","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.4049\/jimmunol.1700314","article-title":"\u03b3\u03b4 T cells are required for the induction of sterile immunity during irradiated sporozoite vaccinations","volume":"199","author":"Zaidi","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib48","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3390\/vaccines8020264","article-title":"Role of opsonophagocytosis in immune protection against malaria","volume":"8","author":"Leitner","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.coi.2022.102234_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2020.101429","article-title":"Human challenge trials in vaccine development","volume":"50","author":"Sekhar","year":"2020","journal-title":"Semin Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib50","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41541-021-00425-1","article-title":"Preimmunization correlates of protection shared across malaria vaccine trials in adults","volume":"7","author":"Neal","year":"2022","journal-title":"npj Vaccin"},{"key":"10.1016\/j.coi.2022.102234_bib51","doi-asserted-by":"crossref","first-page":"7514","DOI":"10.1016\/j.vaccine.2011.03.083","article-title":"A human Phase I\/IIa malaria challenge trial of a polyprotein malaria vaccine","volume":"29","author":"Porter","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.coi.2022.102234_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nri2902","article-title":"Experimental human challenge infections can accelerate clinical malaria vaccine development","volume":"11","author":"Sauerwein","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib53","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fimmu.2019.01227","article-title":"Vaccination with sporozoites: models and correlates of protection","volume":"10","author":"Goh","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.medj.2021.03.014","article-title":"Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination","volume":"2","author":"Minassian","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.coi.2022.102234_bib55","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2101718118","article-title":"Old vaccines for new infections: exploiting innate immunity to control COVID-19 and prevent future pandemics","volume":"118","author":"Chumakov","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2022.102234_bib56","first-page":"355","article-title":"Non-specific immunological effects of selected routine childhood immunisations: systematic review","volume":"355","author":"Kandasamy","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.coi.2022.102234_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaf1098","article-title":"Trained immunity: a program of innate immune memory in health and disease","volume":"352","author":"Netea","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102234_bib58","unstructured":"Overview of the Immune System | NIH: National Institute of Allergy and Infectious Diseases. [date unknown]."},{"key":"10.1016\/j.coi.2022.102234_bib59","first-page":"166","article-title":"Overview of the Immune System","volume":"18","author":"Qadri","year":"2018","journal-title":"NIH"},{"key":"10.1016\/j.coi.2022.102234_bib60","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1905047","article-title":"Efficacy of typhoid conjugate vaccine in Nepal: an interim analysis of a participant-and observer-blinded randomized phase III trial","volume":"381","author":"Shakya","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2022.102234_bib61","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2022.102234_bib62","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1080\/21645515.2019.1606971","article-title":"Serum IgG antibodies to Shigella lipopolysaccharide antigens \u2013 a correlate of protection against shigellosis","volume":"15","author":"Cohen","year":"2019","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.coi.2022.102234_bib63","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/imm.13000","article-title":"The essential role of complement in antibody-mediated resistance to Salmonella","volume":"156","author":"Rossi","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.coi.2022.102234_bib64","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/infdis\/jiu045","article-title":"Sequential acquisition of T cells and antibodies to nontyphoidal Salmonella in Malawian children","volume":"210","author":"Nyirenda","year":"2014","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coi.2022.102234_bib65","doi-asserted-by":"crossref","first-page":"224","DOI":"10.4161\/gmic.1.4.12613","article-title":"Immune responses to gut microbiota-commensals and pathogens","volume":"1","author":"Tanoue","year":"2010","journal-title":"Gut Microbes"},{"key":"10.1016\/j.coi.2022.102234_bib66","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nri.2016.88","article-title":"Immunological aspects of intestinal mucus and mucins","volume":"16","author":"V Johansson","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib67","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.immuni.2014.08.009","article-title":"TLR5-mediated sensing of gut microbiota is necessary for antibody responses to seasonal influenza vaccination","volume":"41","author":"Oh","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2022.102234_bib68","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s40265-018-0941-3","article-title":"The significance of the intestinal microbiome for vaccinology: from correlations to therapeutic applications","volume":"78","author":"Harris","year":"2018","journal-title":"Drugs"},{"key":"10.1016\/j.coi.2022.102234_bib69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.chom.2018.07.005","article-title":"Effect of antibiotic-mediated microbiome modulation on rotavirus vaccine immunogenicity: a human, randomized-control proof-of-concept trial","volume":"24","author":"Harris","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coi.2022.102234_bib70","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.cell.2019.08.010","article-title":"Antibiotics-driven gut microbiome perturbation alters immunity to vaccines in humans","volume":"178","author":"Hagan","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.coi.2022.102234_bib71","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1128\/IAI.68.7.3830-3839.2000","article-title":"Correlations between antibody immune responses at different mucosal effector sites are controlled by antigen type and dosage","volume":"68","author":"Externest","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.coi.2022.102234_sbref69","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201116","article-title":"Vi-specific serological correlates of protection for typhoid fever","volume":"218","author":"Jin","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.coi.2022.102234_bib73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coi.2022.102234_bib74","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tube.2017.11.006","article-title":"Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines","volume":"108","author":"Harris","year":"2018","journal-title":"Tuberculosis"},{"key":"10.1016\/j.coi.2022.102234_bib75","first-page":"167","article-title":"Bacillus calmette guerin","volume":"7","author":"Okafor","year":"2022","journal-title":"Clin Tube Diagn Treat"},{"key":"10.1016\/j.coi.2022.102234_sbref73","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/s41586-019-1817-8","article-title":"Prevention of tuberculosis in macaques after intravenous BCG immunization","volume":"577","author":"Darrah","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.coi.2022.102234_sbref74","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1038\/s41590-021-01066-1","article-title":"Robust IgM responses following intravenous vaccination with Bacille Calmette\u2013Gu\u00e9rin associate with prevention of Mycobacterium tuberculosis infection in macaques","volume":"22","author":"Irvine","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib78","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1126\/science.1241800","article-title":"Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine","volume":"341","author":"Seder","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102234_bib79","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1073\/pnas.1303834110","article-title":"response to a liver-stage Plasmodium antigen is not boosted by repeated sporozoite immunizations","volume":"110","author":"Murphy","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2022.102234_bib80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJMoa2116298","article-title":"Evaluation of the BNT162b2 Covid-19 vaccine in children 5 to 11 years of age","volume":"386","author":"Walter","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coi.2022.102234_bib81","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101344","article-title":"Comparing the longer-term effectiveness of a single dose of the Pfizer-BioNTech and Oxford-AstraZeneca COVID-19 vaccines across the age spectrum","volume":"46","author":"Kaura","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.coi.2022.102234_bib82","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0140-6736(21)00234-8","article-title":"Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia","volume":"397","author":"Logunov","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.coi.2022.102234_bib83","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.immuni.2020.12.003","article-title":"Distinct developmental pathways from blood monocytes generate human lung macrophage diversity","volume":"54","author":"Evren","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.coi.2022.102234_bib84","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1089\/ars.2017.7310","article-title":"Epigenetics and trained immunity","volume":"29","author":"Van Der Heijden","year":"2018","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.coi.2022.102234_bib85","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","article-title":"Single-cell multi-omics analysis of the immune response in COVID-19","volume":"27","author":"Stephenson","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.coi.2022.102234_bib86","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1126\/science.abd7331","article-title":"Learning the language of viral evolution and escape","volume":"371","author":"Hie","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.coi.2022.102234_bib87","first-page":"46","article-title":"Beyond binding: antibody effector functions in infectious diseases","volume":"18","author":"Lu","year":"2017","journal-title":"Nat Publ Gr"},{"key":"10.1016\/j.coi.2022.102234_bib88","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fimmu.2020.01450","article-title":"Viral evasion of the complement system and its importance for vaccines and therapeutics","volume":"11","author":"Mellors","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib89","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.it.2020.12.002","article-title":"Complement factors in COVID-19 therapeutics and vaccines","volume":"42","author":"Kurtovic","year":"2021","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coi.2022.102234_bib90","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1038\/s41564-020-00789-5","article-title":"Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies","volume":"5","author":"Lee","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.coi.2022.102234_bib91","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/14760584.2019.1604231","article-title":"Selection of adjuvants for vaccines targeting specific pathogens","volume":"18","author":"Sarkar","year":"2019","journal-title":"Expert Rev Vaccin"},{"key":"10.1016\/j.coi.2022.102234_bib92","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coi.2022.102234_bib93","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2106433118","article-title":"Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaques","volume":"118","author":"King","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coi.2022.102234_bib94","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1182\/bloodadvances.2017011411","article-title":"Innate transcriptional effects by adjuvants on the magnitude, quality, and durability of HIV envelope responses in NHPs","volume":"1","author":"Francica","year":"2017","journal-title":"Blood Adv"},{"key":"10.1016\/j.coi.2022.102234_sbref92","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.15585\/mmwr.mm7038e1","article-title":"Comparative effectiveness of moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising conditions - United States, March\u2013August 2021","volume":"70","author":"Self","year":"2021","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.coi.2022.102234_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2021.198466","article-title":"Adenoviral vector DNA- and SARS-CoV-2 mRNA-based Covid-19 vaccines: possible integration into the human genome - are adenoviral genes expressed in vector-based vaccines?","volume":"302","author":"Doerfler","year":"2021","journal-title":"Virus Res"},{"key":"10.1016\/j.coi.2022.102234_bib97","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12979-020-00181-1","article-title":"The immune response to influenza in older humans: beyond immune senescence","volume":"17","author":"McElhaney","year":"2020","journal-title":"Immun Ageing"}],"container-title":["Current Opinion in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791522000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0952791522000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:46:04Z","timestamp":1760604364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0952791522000814"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":97,"alternative-id":["S0952791522000814"],"URL":"https:\/\/doi.org\/10.1016\/j.coi.2022.102234","relation":{},"ISSN":["0952-7915"],"issn-type":[{"value":"0952-7915","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The next frontier in vaccine design: blending immune correlates of protection into rational vaccine design","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coi.2022.102234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102234"}}